Full Text View
Tabular View
No Study Results Posted
Related Studies
The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
This study has been completed.
Study NCT00001628   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atherosclerosis
Heart Failure, Congestive
Hypertension
Myocardial Infarction
Additional conditions recognized in this trial
Heart Failure
Infarction
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Additional drug interventions recognized in this trial
Angiotensin II
Angiotensin II Type 1 Receptor Blockers
More general drug interventions related to this trial
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services